Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the next stage in Europe. The European Medicines Agency has validated the application. That basically means the file is…
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the…
Transcosmos established a partnership with Tokyo University of Pharmacy and Life Sciences.…
Curatis Holding AG has signed an exclusive licensing and development agreement with…
CMIC Co., Ltd., a contract research organization jointly owned by Blackstone and…
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd.…
Astellas Pharma Inc. and Vir Biotechnology, Inc. are teaming up globally to…
Japan is at the forefront of healthcare innovation by becoming the first…
Australian diagnostics innovator Q, Sera Pty Ltd has announced that its patented…
Eisai Co., Ltd. and Nuvation Bio Inc. have pushed taletrectinib into the…
Transcosmos established a partnership with Tokyo University of Pharmacy and Life Sciences.…
Curatis Holding AG has signed an exclusive licensing and development agreement with…
CMIC Co., Ltd., a contract research organization jointly owned by Blackstone and…
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd.…
Astellas Pharma Inc. and Vir Biotechnology, Inc. are teaming up globally to…
Japan is at the forefront of healthcare innovation by becoming the first…
Australian diagnostics innovator Q, Sera Pty Ltd has announced that its patented…
Sign in to your account